File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy

TitleExpression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy
Authors
Huang, PYZeng, TBan, XLi, MQZhang, BZZhu, YHHua, WFMai, HQZhang, LGuan, XLi, Y
KeywordsEIF5A2
Gene amplification
Nasopharyngeal carcinoma
Prognosis
Issue Date2016
PublisherBioMed Central Ltd. The Journal's web site is located at http://www.biomedcentral.com/bmccancer/
Citation
BMC Cancer, 2016, v. 16, p. 669:1-9 How to Cite?
DOI: http://dx.doi.org/10.1186/s12885-016-2714-2
Persistent Identifierhttp://hdl.handle.net/10722/242189
ISSN
1471-2407
2021 Impact Factor: 4.638
2020 SCImago Journal Rankings: 1.358
PubMed Central ID
PMC4994420
ISI Accession Number ID
WOS:000384191600001

 

DC FieldValueLanguage
dc.contributor.authorHuang, PY-
dc.contributor.authorZeng, T-
dc.contributor.authorBan, X-
dc.contributor.authorLi, MQ-
dc.contributor.authorZhang, BZ-
dc.contributor.authorZhu, YH-
dc.contributor.authorHua, WF-
dc.contributor.authorMai, HQ-
dc.contributor.authorZhang, L-
dc.contributor.authorGuan, X-
dc.contributor.authorLi, Y-
dc.date.accessioned2017-07-24T01:36:31Z-
dc.date.available2017-07-24T01:36:31Z-
dc.date.issued2016-
dc.identifier.citationBMC Cancer, 2016, v. 16, p. 669:1-9-
dc.identifier.issn1471-2407-
dc.identifier.urihttp://hdl.handle.net/10722/242189-
dc.languageeng-
dc.publisherBioMed Central Ltd. The Journal's web site is located at http://www.biomedcentral.com/bmccancer/-
dc.relation.ispartofBMC Cancer-
dc.rightsBMC Cancer. Copyright © BioMed Central Ltd.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectEIF5A2-
dc.subjectGene amplification-
dc.subjectNasopharyngeal carcinoma-
dc.subjectPrognosis-
dc.titleExpression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy-
dc.typeArticle-
dc.identifier.emailGuan, X: xyguan@hku.hk-
dc.identifier.authorityGuan, X=rp00454-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1186/s12885-016-2714-2-
dc.identifier.pmcidPMC4994420-
dc.identifier.scopuseid_2-s2.0-84983033981-
dc.identifier.hkuros273287-
dc.identifier.volume16-
dc.identifier.spage669:1-
dc.identifier.epage9-
dc.identifier.isiWOS:000384191600001-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1471-2407-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats